The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the management of hidradenitis suppurativa (HS). The document aims to: offer an appraisal of all relevant literature up to July 2018, focusing on any key developments; address important, practical clinical questions relating to the primary guideline objective; provide guideline recommendations and, if appropriate, research recommendations.
The guideline is presented as a detailed review with highlighted recommendations for practical use in primary care and secondary care, in addition to an updated Patient Information Leaflet [available on the British Association of Dermatologists (BAD) website, www.bad.org.uk/leaflets].